Literature DB >> 2320748

Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation.

J M Taylor1, H R Withers, W M Mendenhall.   

Abstract

The dose-time factors in the external beam treatment of 473 patients with squamous cell carcinoma of the pharyngeal wall, vocal cord, pyriform sinus or supraglottic larynx were considered. The effect of overall treatment time on the tumor response was quantified by estimating the increment in dose per day needed to achieve a constant rate of local control, that is, the dose required to counterbalance the effect of growth of the tumor during irradiation. The estimated increment in isoeffect dose per day varies between sites, however, the increments, although estimated with considerable uncertainty, are in general larger than 1 Gy per day. These estimates are consistent with accelerated tumor clonogen repopulation during irradiation.

Entities:  

Mesh:

Year:  1990        PMID: 2320748     DOI: 10.1016/0167-8140(90)90096-f

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

Authors:  M Maciá I Garau; J Solé Monné; M J Cambra Serés; C Monfà Binefa; M Peraire Llopis
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

2.  Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.

Authors:  Wu-Zhe Zhang; Jian-Zhou Chen; De-Rui Li; Zhi-Jian Chen; Hong Guo; Ting-Ting Zhuang; Dong-Sheng Li; Ming-Zhen Zhou; Chuang-Zhen Chen
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

3.  Does treatment duration affect outcome after radiotherapy for prostate cancer?

Authors:  David J D'Ambrosio; Tianyu Li; Eric M Horwitz; David Y T Chen; Alan Pollack; Mark K Buyyounouski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-09       Impact factor: 7.038

Review 4.  Squamous-cell carcinoma of the anus: progress in radiotherapy treatment.

Authors:  Rob Glynne-Jones; David Tan; Robert Hughes; Peter Hoskin
Journal:  Nat Rev Clin Oncol       Date:  2016-01-27       Impact factor: 66.675

Review 5.  Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

Authors:  José A González Ferreira; Javier Jaén Olasolo; Ignacio Azinovic; Branislav Jeremic
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-04

6.  Evaluation of Factors in Relation with the Non-Compliance to Curative Intent Radiotherapy among Patients of Head and Neck Carcinoma: A Study from the Kumaon Region of India.

Authors:  Kailash Chandra Pandey; Swaroop Revannasiddaiah; Nirdosh Kumar Pant
Journal:  Indian J Palliat Care       Date:  2015 Jan-Apr

7.  Compliance to therapy-elderly head and neck carcinoma patients.

Authors:  Aman Sharma; Renu Madan; Rajeev Kumar; Prem Sagar; Vineet K Kamal; Alok Thakar; Atul Sharma; Bidhu K Mohanti
Journal:  Can Geriatr J       Date:  2014-09-05

8.  Conventional fractionation should not be the standard of care for T2 glottic cancer.

Authors:  Lynne M Dixon; Catriona M Douglas; Shazril Imran Shaukat; Kate Garcez; Lip Wai Lee; Andrew J Sykes; David Thomson; Nicholas J Slevin
Journal:  Radiat Oncol       Date:  2017-11-14       Impact factor: 3.481

9.  The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.

Authors:  Rūta Grigiene; Konstantinas P Valuckas; Eduardas Aleknavicius; Juozas Kurtinaitis; Simona R Letautiene
Journal:  BMC Cancer       Date:  2007-12-22       Impact factor: 4.430

10.  Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study.

Authors:  Jianzhou Chen; Hong Guo; Tiantian Zhai; Daniel Chang; Zhijian Chen; Ruihong Huang; Wuzhe Zhang; Kun Lin; Longjia Guo; Mingzhen Zhou; Dongsheng Li; Derui Li; Chuangzhen Chen
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.